• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
RMTI

RMTI

Rockwell Medical, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD0.68

-0.03 (-4.71%)

Rating:C

Company Profile

CEO

Mark Strobeck

IPO Date

1998-01-27

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.72

Prev. Close

$0.71

Day Low

$0.67

Day High

$0.72

52W Low

$0.66

52W High

$2.10

Market Cap

$0.03B

Volume

0.58M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBearish

Articles

10

Avg Positive

18.6%

Avg Negative

29.9%

Avg Neutral

51.3%

News Feed

Rockwell Medical, Inc. Files Pre-IND Meeting Request with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion

GlobeNewsWire·6/28/2021·↑ positive

Rockwell Medical's (RMTI) CEO Russell Ellison on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/17/2021·↓ negative

Recap: Rockwell Medical Q1 Earnings

Benzinga·5/17/2021·↓ negative

Rockwell Medical, Inc. Provides First Quarter 2021 Financial and Operational Update

GlobeNewsWire·5/17/2021·↑ positive

Moving Average Crossover Alert: Rockwell Medical (RMTI)

Zacks Investment Research·4/26/2021·↓ negative

Rockwell Medical Presents Data on Diagnosis and Management of Iron Deficiency Anemia in Home Parenteral Nutrition Patients at the NHIA 2021 Annual Conference

GlobeNewsWire·4/22/2021·↑ positive

Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/31/2021·↓ negative

Rockwell Medical (RMTI) Reports Q4 Loss, Lags Revenue Estimates

Zacks Investment Research·3/31/2021·↑ positive

Rockwell Medical: Q4 Earnings Insights

Benzinga·3/31/2021·↓ negative

Rockwell Medical, Inc. Provides Fourth Quarter and Full Year 2020 Financial and Operational Update

GlobeNewsWire·3/31/2021·↑ positive